Management of hyperglycemia in hospitalized adult patients in non-critical care settings: an Endocrine Society clinical practice guideline

MT Korytkowski, R Muniyappa… - The Journal of …, 2022 - academic.oup.com
Background Adult patients with diabetes or newly recognized hyperglycemia account for
over 30% of noncritically ill hospitalized patients. These patients are at increased risk for …

16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2023

NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2023 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

[HTML][HTML] 16. Diabetes care in the hospital: Standards of Care in Diabetes—2024

American Diabetes Association Professional … - Diabetes …, 2023 - pmc.ncbi.nlm.nih.gov
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2024

Diabetes Care, 2024 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

Real-world accuracy of CGM in inpatient critical and noncritical care settings at a safety-net hospital

E Finn, L Schlichting, L Grau, IS Douglas… - Diabetes …, 2023 - Am Diabetes Assoc
OBJECTIVE We sought to determine real-world accuracy of inpatient continuous glucose
monitoring (CGM) at multiple levels of acuity in a large safety-net hospital. RESEARCH …

Accuracy and Potential Interferences of CGM sensors in the Hospital

V Bellido, G Freckman, A Pérez, RJ Galindo - Endocrine Practice, 2023 - Elsevier
For years, the standard-of-care for monitoring dysglycemia in hospitalized patients was
capillary blood glucose (CBG) testing with point-of-care glucose meters. Recently, there has …

The adverse effects profile of teprotumumab

MN Stan, CC Krieger - The Journal of Clinical Endocrinology & …, 2023 - academic.oup.com
Context Teprotumumab therapy for thyroid eye disease (TED) patients represents a major
step forward. It targets and inhibits the insulin-like growth factor-1 receptor (IGF-1R), and its …

A global plastics treaty to protect endocrine health

L Trasande - The Lancet Diabetes & Endocrinology, 2022 - thelancet.com
Plastics are increasingly straining water systems and wildlife. The UN responded on May 30,
2022, by launching treaty negotiations in Dakar, Senegal, for an internationally legally …

Gaps in our knowledge of managing inpatient dysglycaemia and diabetes in non‐critically ill adults: A call for further research

KK Dhatariya, G Umpierrez - Diabetic Medicine, 2023 - Wiley Online Library
Aims To describe the gaps in knowledge for the care of people in the hospital who have
dysglycaemia or diabetes. Methods A review of the current literature and the authors' …

PeRiOperative Glucose PRAgMatic (PROGRAM) trial protocol and statistical analysis plan for comparing automated intraoperative reminders to standardise insulin …

M Zapf, D Patel, P Henson, MD McEvoy, E Huang… - BMJ open, 2023 - bmjopen.bmj.com
Introduction Studies finding perioperative hyperglycaemia is associated with adverse patient
outcomes in surgical procedures spurred the development of blood glucose guidelines at …